# Dexmedetomidine in Mechanically Ventilated Neonates With Single-Organ Respiratory Failure.

> **NCT01266252** · PHASE3 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 35 (actual)

## Conditions studied

- Mechanically-ventilated Neonates With Single-organ Respiratory Failure

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT01266252
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07-28
- **Primary completion:** 2017-04-20
- **Final completion:** 2018-04-10
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2019-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01266252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01266252, "Dexmedetomidine in Mechanically Ventilated Neonates With Single-Organ Respiratory Failure.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01266252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*